Orlistat Therapy for Obesity Linked to Fewer Major Adverse Cardiovascular Events
A team of UK-based investigators explored the long-term cardiovascular outcomes in patients with obesity who were administered orlistat therapy.
End-Stage Renal Disease
Score Assesses Health-Related QOL in Patients With Kidney Failure
Study supports validity of preference-based health utility score for patients undergoing hemodialysis, recent recipients of kidney transplants
Natural Immunity to COVID-19 Virus Less Robust in the Dialysis Population
Recent evidence suggests that patients with end-stage kidney disease may not mount as robust an immune response to SARS-CoV-2 as healthy individuals.
Intradialytic Cycling Linked to Cardiovascular Benefits
A 6-month program of intra-dialytic cycling improved left ventricular mass.
CKD Hospitalization Patterns May Predict ESKD, Death Risks
Three simple hospitalization trajectories may identify individuals with CKD who are at high risk for kidney failure and early mortality, according to investigators.
In-Center Nocturnal Hemodialysis May Improve HRQOL
In a small Canadian study, investigators found that patients switched from conventional to in-center nocturnal hemodialysis experience improvements in various measures of health-related quality of life, especially mental health.
Primary Nephrotic Syndrome Increases ESKD, Cardiovascular Risks
Among the study findings, primary nephrotic syndrome was associated with an excess risk of heart failure hospitalization.
Many Priority Patients Fail To Be Placed on Kidney Transplant Waitlist
Delays in waitlisting can result in some patients losing their priority status for high-quality deceased donor kidneys with the lowest risk of failure.
Third COVID-19 Vaccine Dose Shows Variable Efficacy in Solid Organ Transplant Recipients
In a case series, SARS-CoV-2 antibody titers increased after the third dose in a third of patients who previously had no response to vaccination.
Excess Deaths Estimated for ESRD Patients During COVID-19
Excess deaths estimated at 8.7 to 12.9 per 1000 ESRD patients, representing a total of 6953 to 10,316 excess deaths
- Loading...
Loading...
Next post in End-Stage Renal Disease
Loading... 
Loading...